1 insider bought €8,901 of shares over the last 90 days, the latest by 김현일, filed 18 Sept 2026.
Optipharm.CO.,Ltd: what insiders have been doing
Optipharm.CO.,Ltd belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Between 6 November 2025 and 6 November 2026, 1 insider published 4 filings.
The flow runs one way only: 1 insider bought (4 purchases totalling €5,670) and nobody sold on the market. No amount is published for 3 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €5,670 from 김현일, disclosed on 29 May 2026. On the buying side, the filings list 1 chief executive among the declarants.
The most recent open-market purchase was published on 18 September 2026, 53 days ago.
Compared with its exchange (2,657 companies, median 7 filings), a count of 4 filings is below the norm. Since 2021, the database holds 36 purchases and 1 sale by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -0.6%Entry ₩4,625 · Close 04 Nov 2026 ₩4,595
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 3,000 sharesShareKRXDART:20260918000277Canonical exit: 17 Dec 2026 (T+90)
- 2,000 sharesShareKRXDART:20260629000353Canonical exit: 27 Sept 2026 (T+90)
- 2,000 shares@ ₩4,956.2725100.0% of flowShareKRXDART:20260529001448Canonical exit: 19 Aug 2026 (T+90)
- 7,000 sharesShareKRXDART:20260127000243Canonical exit: 27 Apr 2026 (T+90)
- 1,000 sharesShareKRXDART:20251001000509Canonical exit: 30 Dec 2025 (T+90)
- 2,000 sharesShareKRXDART:20250903000235Canonical exit: 2 Dec 2025 (T+90)
- 2,220 sharesShareKRXDART:20250610000233Canonical exit: 8 Sept 2025 (T+90)
- 4,000 sharesShareKRXDART:20250411002499Canonical exit: 10 Jul 2025 (T+90)
- 4,232 sharesShareKRXDART:20241210000383Canonical exit: 10 Mar 2025 (T+90)
- 4,000 sharesShareKRXDART:20241120000218Canonical exit: 18 Feb 2025 (T+90)
- 4,000 sharesShareKRXDART:20241104000210Canonical exit: 2 Feb 2025 (T+90)
- ShareKRXDART:20240925000358Canonical exit: 18 Dec 2024 (T+90)
- ShareKRXDART:20240820000247Canonical exit: 10 Nov 2024 (T+90)
- 10,000 shares@ ₩6,301.0073.7% of flowShareKRXDART:20240315000703Canonical exit: 6 Jun 2024 (T+90)
- ShareKRXDART:20230825000410Canonical exit: 16 Nov 2023 (T+90)
- ShareKRXDART:20230728000500Canonical exit: 19 Oct 2023 (T+90)
- ShareKRXDART:20230714000114Canonical exit: 5 Oct 2023 (T+90)
- ShareKRXDART:20230703000114Canonical exit: 24 Sept 2023 (T+90)
- ShareKRXDART:20230517000281Canonical exit: 13 Aug 2023 (T+90)
- 26,496 sharesKRXDART:20230517000275
- ShareKRXDART:20230324000226Canonical exit: 22 Jun 2023 (T+90)
- ShareKRXDART:20230223000891Canonical exit: 24 May 2023 (T+90)
- 1,966 shares@ ₩6,720.623616.7% of flowShareKRXDART:20230113000179Canonical exit: 6 Apr 2023 (T+90)
- ShareKRXDART:20221228000022Canonical exit: 28 Mar 2023 (T+90)
25 of 39 declarations
About Optipharm.CO.,Ltd
OptiPharm is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
